#pharmastocks
pharmastocks
141 рет көрілді
4 адам талқылап жатыр
Қызу саудада
Ең соңғы
·
--
#EarningsSeason
🚀 $LLY Earnings Preview: Can Weight-Loss Drug Demand Drive a Bullish Breakout?
💊 $LLY reports Q3 2026 earnings on October 29. Analysts expect strong revenue growth, driven by rising demand for Mounjaro and Zepbound, its diabetes and weight-loss treatments. However, earnings expectations and drug pricing pressures could influence the market reaction.
📊 My Prediction is Bullish on LLY.
Why? Strong demand for obesity and diabetes drugs could support revenue growth, while future pipeline developments offer additional growth potential. The key catalysts are earnings results, forward guidance, and sales momentum.
🎯 Question: How do you expect $LLY stock to move after earnings—BULLISH 📈 or BEARISH 📉?
#LLY #EarningsSeason #StockMarket #PharmaStocks #Investing
{stock_us}(LLY.US)
#EarningsSeason
🚀 $LLY Earnings Preview: Can Weight-Loss Drug Demand Drive a Bullish Breakout?
💊 $LLY reports Q3 2026 earnings on October 29. Analysts expect strong revenue growth, driven by rising demand for Mounjaro and Zepbound, its diabetes and weight-loss treatments. However, earnings expectations and drug pricing pressures could influence the market reaction.
📊 My Prediction is Bullish on LLY.
Why? Strong demand for obesity and diabetes drugs could support revenue growth, while future pipeline developments offer additional growth potential. The key catalysts are earnings results, forward guidance, and sales momentum.
🎯 Question: How do you expect $LLY stock to move after earnings—BULLISH 📈 or BEARISH 📉?
#LLY #EarningsSeason #StockMarket #PharmaStocks #Investing
🚀 $LLY Earnings Preview: Can Weight-Loss Drug Demand Drive a Bullish Breakout?
💊 $LLY reports Q3 2026 earnings on October 29. Analysts expect strong revenue growth, driven by rising demand for Mounjaro and Zepbound, its diabetes and weight-loss treatments. However, earnings expectations and drug pricing pressures could influence the market reaction.
📊 My Prediction is Bullish on LLY.
Why? Strong demand for obesity and diabetes drugs could support revenue growth, while future pipeline developments offer additional growth potential. The key catalysts are earnings results, forward guidance, and sales momentum.
🎯 Question: How do you expect $LLY stock to move after earnings—BULLISH 📈 or BEARISH 📉?
#LLY #EarningsSeason #StockMarket #PharmaStocks #Investing
LLY-0,40%
LLYUS-0,35%
82
Көбірек контент көру үшін кіріңіз
Binance Square платформасында әлемдік криптоқоғамдастыққа қосылыңыз
⚡️ Криптовалюта туралы ең соңғы және пайдалы ақпаратты алыңыз.
💬 Әлемдегі ең ірі криптобиржаның сеніміне ие.
👍 Расталған авторлардың нақты пікірлерін табыңыз.
Электрондық пошта/телефон нөмірі
Трендтегі тақырыптар
1
#CanMicrosoftDeliverOnAI
228,880 рет көрілді
1,904 адам талқылап жатыр
2
#CanGoogleDefindItsCore
130,602 рет көрілді
1,398 адам талқылап жатыр
3
#EarningsSeason
5.8M рет көрілді
27,881 адам талқылап жатыр
4
#BitcoinSurpasses$81K
1,160 рет көрілді
28 адам талқылап жатыр
5
#RobinhoodFalls8.4%AfterItsResults
0 рет көрілді
1 адам талқылап жатыр
6
#KOSPISurges6.63%BackAbove6000
463 рет көрілді
37 адам талқылап жатыр
7
#DatavaultAICantWithdrawBitcoinFromBiconomy
1,555 рет көрілді
58 адам талқылап жатыр
8
#FOMCWatch
9.2M рет көрілді
29,094 адам талқылап жатыр
9
#HKPlacesTokenizedFundSecondaryTradingUnderETFLikeFramework
629 рет көрілді
30 адам талқылап жатыр
10
#USGovSellsFTXLinkedAnthropicSharesFor$627M
941 рет көрілді
29 адам талқылап жатыр